壳聚糖交联微球的制备
[Abstract]:Microsphere dosage form is one of the key directions of the present preparation. The microspheres can reduce the degradation rate of the medicine and improve the stability of the medicine. The microspheres prepared by the single cross-linking agent have good slow-release property, but can not realize effective controlled release. In this paper,5-fluorouramide drug-loaded microspheres were prepared by cross-linking of Beijing-Niping and vanillin, and the release rate of the microspheres was controlled by adjusting the cross-linking agent. In this paper, the conditions of the preparation of microspheres by a single cross-linking agent are selected. On the basis of this condition, the optimal conditions for preparing the microspheres by the compound cross-linking agent were determined, and the drug-loaded microspheres were prepared by adding 5-fluorouramide. The highest drug-carrying amount of the drug-loaded microspheres was 2.97% and the encapsulation rate was 20.27% by HPLC. The prepared microspheres have good dispersivity and uniform particle size distribution, and the particle size range is about 10-20 & mu; m; and the FT-IR spectrum results show that both the Jingyi and the vanillin are cross-linked with the chitosan; and the swelling performance results show that the swelling rate of the microspheres prepared by the cross-linking agent of different compounding proportions is different, The results show that the microspheres have different release rates. The results of the XRD pattern show that the microspheres were successfully cross-linked, and the DSC-TGA pattern confirmed that the 5-fluorouramide was inside the microspheres, and the stability of the 5-fluorouramide was improved. With reference to the existing national standard, the release performance of 5-fluorouramide drug-loaded microspheres was studied. The maximum cumulative release rate of the microballoon was 97.2% in the buffer solution of pH = 3.6, and the maximum cumulative release rate was 94.2% in the buffer solution of pH = 7.4. Therefore, the effect of controlling the release rate can be achieved by controlling the compounding ratio of the cross-linking agent. The stability of the microspheres was studied under the conditions of high temperature, high light and high humidity.
【学位授予单位】:河北科技大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:TQ460.1;O636.1
【参考文献】
相关期刊论文 前10条
1 王笛笛;管冬冬;田珊;韩顺玉;;壳聚糖功能化修饰的复合微球研究进展[J];广东化工;2017年01期
2 吴成城;贾子平;冯敬飞;胡连升;;Rathke囊肿的诊断和手术治疗[J];中国冶金工业医学杂志;2016年06期
3 刘德杰;张慧;安飞;翟光喜;;生物黏附微球的研究进展[J];药学研究;2016年08期
4 孙智纯;王兵;单娟娟;司汇通;;香草醛分子印迹聚合物微球的合成及表征[J];现代食品科技;2015年09期
5 赵崇涛;张立英;;我国儿童肿瘤疾病的发展状况及预防的初探[J];中国民康医学;2015年12期
6 冯淑莹;;壳聚糖载药微球的制备及其应用进展[J];广东化工;2015年07期
7 赵暖暖;仵文英;张抗怀;王娜;;HPLC法测定5-氟尿嘧啶纳米粒的药物包封率[J];药物分析杂志;2014年05期
8 熊华;胡振瀛;王素芳;彭海龙;;京尼平交联壳聚糖微球的制备及理化性质[J];南昌大学学报(工科版);2013年04期
9 杨子明;彭政;周敏;李思东;庞玉新;李虹;李普旺;;壳聚糖靶向缓释功能高分子载药微球及其特性研究[J];功能材料;2013年12期
10 王忠云;杨秀芹;杨君东;李晓剑;;5-氟尿嘧啶配制时间与药物稳定性研究[J];中国医药科学;2012年18期
相关硕士学位论文 前2条
1 张溢琼;基于核壳结构的纳微粒程序性控制给药系统的研究[D];重庆大学;2011年
2 王媛媛;抗肿瘤药物(5-氟尿嘧啶)的缓释作用研究[D];东北师范大学;2010年
,本文编号:2486116
本文链接:https://www.wllwen.com/kejilunwen/huaxue/2486116.html